“Instead, cannabis use is associated with increased central airway resistance, lung hyperinflation, and higher vital capacity with little evidence of airflow obstruction or impairment of gas transfer,” they added. While smoking tobacco has been found to cause cancer and COPD, the researchers concluded there isn’t enough evidence to say the same about cannabis.
“An association between cannabis and lung cancer remains unproven, with studies providing conflicting findings,” the researchers said. “We are still clearly trying to determine if cannabis smoking definitely causes irreversible lung damage and, if so, what makes people more susceptible to lung damage,” Carey S. Clark, PhD, chair of the Medical Cannabis Program at Pacific College of Health and Science in San Diego, told Healthline.
The benefit in inhaled cannabis is that it acts more immediately and for those suffering from pain and nausea, this effect can bring about more timely relief of symptoms,” she said. Researchers looked at data from a general population sample and considered whether mental health issues in mothers were apparent before the use of cannabis.
The parts that grow above the ground are used to make medicine. People use wallflower for heart problems, constipation, liver disease, and others conditions, but there is no good scientific evidence to support these uses. Side Effects When taken by mouth : Wallflower is POSSIBLY UNSAFE.
Special Precautions & Warnings: Pregnancy and breast -feeding : It might be POSSIBLY UNSAFE to use wallflower if you are pregnant or breast-feeding. Digoxin (Lanolin) helps the heart beat more strongly.
Low potassium levels can also affect the heart and increase the risk of side effects from wallflower. Some medications for inflammation include dexamethasone (Decadron), hydrocortisone (Cortex), methylprednisolone (Medal), prednisone (Deltas one), and others.
Taking quinidine along with wallflower might cause serious heart problems. Taking quinine along with wallflower might cause serious heart problems.
Low potassium levels can increase the chance of side effects from wallflower. Some stimulant laxatives include bisacodyl (Corrector, Dulcolax), cascara, castor oil (Purge), senna (Snoot), and others.
Water pills (Diuretic drugs) interacts with WALLFLOWER Low potassium levels can also affect the heart and increase the risk of side effects from wallflower.
Some “water pills” that can deplete potassium include chlorothiazide (Diurnal), chlorthalidone (Halftone), furosemide (La six), hydrochlorothiazide (HCTZ, HydroDiuril, Microcode), and others. At this time there is not enough scientific information to determine an appropriate range of doses for wallflower.
Keep in mind that natural products are not always necessarily safe and dosages can be important. Be sure to follow relevant directions on product labels and consult your pharmacist or physician or other healthcare professional before using.
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD.
You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you. This copyrighted material is provided by Natural Medicines Comprehensive Database Consumer Version.
For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.© Therapeutic Research Faculty. 11 Supplements for Menopause Ease hot flashes and other symptoms.
Pamela Jamil warns followers about keto diet My Father-in-law did some research on the net about Glade Scented Plug-ins and found that a number of stores took them off of the shelves about a week ago because they were putting out various chemicals in homes.
Now... he is telling my Husband and I to get rid of our Bath and Body Works Scented Wall Flowers, but a lot of you know, those things do not come cheap. Many electric air freshness contain known carcinogens (cancer causing agents), including methylene chloride and formaldehyde.
Source(s): “Final Exits: The illustrated Encyclopedia of How We Die” by Michael Largo. This man has spent over a decade researching strange and unusual ways to die... electronic air freshness happened to be one OG them.
I have tried Yankee Candle wall plug ins, that are basically the same thing as the wallflowers. That’s the message from a new study presented over the weekend at the annual meeting of the American College of Allergy, Asthma and Immunology (AC AAI).
As researchers have taken a closer look at these seemingly hassle-free devices, they have discovered an astonishing number of toxic compounds are present in many scented gels. According to a study conducted by the Natural Resources Defense Council (NRC), 86% of air fresheners tested contained phthalates.
Phthalates, which are also found in many plastics, aerosol sprays, paints, pesticides, cosmetics, and fragrances, are notoriously disruptive to the body. As the NRC reported in their research, “Most phthalates are well known to interfere with production of the male hormone testosterone, and have been associated with reproductive abnormalities”.
Due to the above findings (and similar corroborative studies), the Consumer Product Safety Commission has issued a general warning about the high phthalate levels present in air fresheners. Preliminary animal studies suggest that these adverse effects are also a genuine, and worrying, possibility in humans.
Even if phthalates are found not to be highly carcinogenic in humans, however, the UK’s Public Health Center for Radiation, Chemical and Environmental Hazards has revealed that air fresheners typically contain another toxic compound that absolutely is: Formaldehyde. It is also known to cause ongoing irritation of the throat and airways, potentially leading to dangerous infections, frequent nosebleeds, asthma, and other respiratory ailments, says the US government’s National Toxicology Program.
Compounding the risks posed by formaldehyde, most major brands of plug-in air fresheners contain a chemical known as naphthalene. As if all the above evidence was not damning enough, plug-in air fresheners have been revealed to contain volatile organic compounds (Vows) as well.
A. C. M. Burger, B. Libero, F. Yard, R. J. L. F. Offend, “A Case of Extreme Gastroparesis due to an Occult Small Cell Cancer of the Lung “, Case Reports in Gastrointestinal Medicine, vol. 1 Department of Internal Medicine, Naans Medici Cent rum Zaandam, P.O.
Ultimately the diagnosis of paraneoplastic Gastroparesis due to an occult small cell cancer of the lung was made. The difficulties in the diagnostic process and the pathogenesis of this very rare manifestation are discussed.
Introduction Gastroparesis, a chronic motility disorder, is characterized by upper gastrointestinal symptoms and leads to delayed gastric emptying. Diabetes with poor glycemic control and postsurgical causes represent the most common etiologies.
Gastroparesis also has been described as a complication of several malignancies, including gastric, pancreatic, gallbladder, esophageal, and lung cancers, as well as leiomyosarcoma. The condition commonly manifests as upper gastrointestinal symptoms, including nausea, vomiting, postprandial fullness, early satiety, abdominal pain, and bloating .
Management of Gastroparesis includes correction of malnutrition, dehydration and electrolyte imbalance, and relief of symptoms by use of pro kinetic drugs. The prevalence of paraneoplastic Gastroparesis is unknown, and this entity probably is widely under recognized and under treated.
A case of extreme Gastroparesis that ultimately proved to be due to an occult small cell carcinoma of the lung is presented. Case Report A 74-year-old male patient was presented in the emergency department of our hospital because of repeated vomiting.
He was known with complaints of prostate enlargement and hypertension, smoked for many years, and used excessive amounts of alcohol. Eight months earlier he was seen at the out-patient clinic because of malaise, pain in the proximal muscles, anorexia, a feeling of fullness in the abdomen, mild anemia, and an erythrocyte sedimentation rate of 48 mm.
Polymyalgia rheumatic was suspected and empiric treatment with steroids was started with a remarkable result. On admission physical examination revealed no abnormalities, there were normal hemodynamics, and he was slightly dehydrated.
Routine blood biochemistry was within the normal range, except for a slightly elevated serum calcium content which normalized after rehydration. During this placement repeat histological examination of random biopsies was done which ruled out eosinophilic enteritis.
Because the patient did not tolerate the gastrojejunal tube and because his clinical condition deteriorated parenteral feeding was started. Five and a half hours after ingestion of the test meal the first sign of passage to the duodenum was observed.
Searching the literature and consulting an expert in the field of Gastroparesis revealed that small cell cancer of the lung could be a possible cause. Revision of the chest X-rays did not show any sign of tumor nor enlarged lymph nodes.
However, a CT-scan of the thorax showed enlarged mediastinal lymph nodes and a small lesion in the right lung. Endobronchial ultrasound with fine needle aspiration of a lymph node was consistent with small cell cancer of the lung.
The final diagnosis was paraneoplastic Gastroparesis as a result of an occult small cell cancer of the lung. A CT-scan after two courses of chemotherapy showed a remarkable reduction of the lymph nodes; also the magnitude of the stomach retention decreased significantly.
After completion of the chemotherapy the patient is in clinical remission but still needs parenteral feeding. Retrospectively, the small cell cancer of the lung with the beginning of Gastroparesis already had to be present eight months earlier.
Generally, paraneoplastic syndromes occur in 7–15% of cancer patients and can involve all the organic systems of the human body with different frequencies . Neurological involvement is found in only 0.01% of cancer patients and can be sensory, motor, mixed somatic, or autonomic leading to various syndromes and disorders .
Gastroparesis is a manifestation of the paraneoplastic involvement of the neuronal bodies of the gastrointestinal tract. However, serological detection of anti-bug autoantibodies suggests an autoimmune destruction of the neuronal plexus of the stomach as the main mechanism for its development .
Autoimmune mechanisms play a crucial role in their development through autoantibodies that directs against ligand- or voltage-gated channels to cause changes in synaptic function or neuronal excitability . Anti-bug autoantibodies have been identified to play a crucial role in the pathogenesis of these paraneoplastic naturopathies.
In patients with unexplained Gastroparesis, testing for anti-bug antibodies, as a valuable marker of small cell lungcancercan be considered in the investigation . In one patient presenting with Gastroparesis surgery was done and the stomach was removed in order to restore passage of liquids and food.
In general, most studies suggest two complementary approaches for the management of paraneoplastic Gastroparesis based on its immune-mediated hypothesis: removal of the antigen source by treating the tumor and suppression of the immune response. Once during endoscopy in order to place a new jejuna tube for feeding, some peristalsis was observed.
This paper describes a patient with Gastroparesis in whom the diagnosis of small cell cancer of the lung ultimately was also made via ultrasound assisted fine needle aspiration. It took sometime of diagnostic thinking, a literature search and the consultation of an expert to come to the correct cause of the Gastroparesis.
The fact that repeated X-rays of the thorax did not show signs of an underlying malignancy certainly made the diagnostic process more difficult. Acknowledgment The authors thank Professor Dr. A. Scout, Gastroenterologist, Department of Gastroenterology, AMC, Amsterdam, for his advice.
View at: Publisher Site | Google Scholar J. E. Stevens, K. L. Jones, C. K. Rather, and M. Horowitz, “Pathophysiology and pharmacotherapy of Gastroparesis: current and future perspectives,” Expert Opinion on Pharmacotherapy, vol. View at: Publisher Site | Google Scholar G. E. Richardson and B. E. Johnson, “Paraneoplastic syndromes in lung cancer, ” Current Opinion in Oncology, vol.
View at: Google Scholar J. Honor and S. Cartalat-Carel, “Advances in paraneoplastic neurological syndromes,” Current Opinion in Oncology, vol. View at: Publisher Site | Google Scholar K. N. Argyriou, M. Peters, J. Ishtar, and S. Elegant, “A rare case of paraneoplastic syndrome presented with severe Gastroparesis due to ganglion loss,” Case Reports in Medicine, vol.
View at: Publisher Site | Google Scholar D. N. Moskovitz and K. V. Rob, “Small cell lung cancer with positive anti-bug antibodies presenting as Gastroparesis,” Canadian Journal of Gastroenterology, vol. View at: Google Scholar M. Swash and M. S. Schwartz, “Paraneoplastic syndromes,” in Current Therapy in Neurologic Disease, R. T. Johnson, Ed., pp.
View at: Google Scholar R. A. Head, D. Zhang, and R. W. McCallum, “Gastroparesis, pseudoachalasia and impaired intestinal motility as paraneoplastic manifestations of small cell lung cancer, ” The American Journal of the Medical Sciences, vol. View at: Publisher Site | Google Scholar N. Prim, B. Menswear, C. Bear et al., “Small cell lung cancer and anti-bug syndrome,” Revue DES Maladies Respirators, vol.
View at: Publisher Site | Google Scholar K. R. Donthireddy, S. Ailawadhi, E. Nasser et al., “Malignant Gastroparesis: pathogenesis and management of an under recognized disorder,” Journal of Supportive Oncology, vol. View at: Google Scholar S. Paula and M. Scatter, “Malignant Gastroparesis: diagnostics and therapeutics,” Journal of Supportive Oncology, vol.
View at: Google Scholar M. Nguyen-tat, J. Poll, E. Günter et al., “Severe paraneoplastic Gastroparesis associated with anti-bug antibodies preceding the manifestation of small-cell lung cancer, ” Zeitschrift fur Gastroenterology, vol. View at: Publisher Site | Google Scholar C. A. Douglas and J. Ellershaw, “Anti-bug antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer, ” Palliative Medicine, vol.
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.